DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
19.53
+0.09 (0.46%)
At close: Jan 24, 2025, 4:00 PM
19.56
+0.03 (0.15%)
After-hours: Jan 24, 2025, 7:17 PM EST
DENTSPLY SIRONA Revenue
DENTSPLY SIRONA had revenue of $951.00M in the quarter ending September 30, 2024, with 0.42% growth. This brings the company's revenue in the last twelve months to $3.90B, down -0.91% year-over-year. In the year 2023, DENTSPLY SIRONA had annual revenue of $3.97B with 1.10% growth.
Revenue (ttm)
$3.90B
Revenue Growth
-0.91%
P/S Ratio
1.03
Revenue / Employee
$260,000
Employees
15,000
Market Cap
3.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
Dec 31, 2019 | 4.02B | 36.00M | 0.90% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.95B |
XRAY News
- 2 days ago - Dentsply Sirona, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. January 27, 2025 Deadline to file Lead Plaintiff Motion - GlobeNewsWire
- 2 days ago - SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA - Accesswire
- 3 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA - PRNewsWire
- 3 days ago - Dentsply Sirona Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before January 27, 2025 to Discuss Your Rights - XRAY - PRNewsWire
- 6 days ago - Dentsply Sirona Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - XRAY - PRNewsWire
- 8 days ago - XRAY Deadline: Rosen Law Firm Urges Dentsply Sirona Inc. (NASDAQ: XRAY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
- 11 days ago - Dentsply Sirona Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – XRAY - GlobeNewsWire
- 16 days ago - The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against DENTSPLY SIRONA Inc. - Accesswire